4D Molecular Therapeutics Inc (FDMT) Transcripts
4D Molecular Therapeutics Inc 4D-150 Phase 2 PRISM Clinical Data Call Transcript
Feb 05, 2024
4D Molecular Therapeutics Inc 4D-710 Phase 1/2 AEROW Interim Clinical Data and Program Update Call Transcript
Nov 01, 2023
4D Molecular Therapeutics Inc at Chardan Genetic Medicines Conference Transcript
Oct 02, 2023
4D Molecular Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
4D Molecular Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 09, 2023
4D Molecular Therapeutics Inc 4D-710 Phase 1/2 AEROW Interim Clinical Data Call Transcript
Jun 07, 2023
4D Molecular Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) Transcript
May 30, 2023
4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023
4D Molecular Therapeutics Inc 4D-150 Phase 1/2 PRISM Interim Clinical Data - Corporate Call Transcript
Apr 27, 2023
4D Molecular Therapeutics Inc 4D-310 Phase 1/2 Interim Clinical Data Call Transcript
Feb 22, 2023
4D Molecular Therapeutics Inc Phase 1/2 Clinical Trial of 4D-150 for Wet AMD - Corporate Call Transcript
Nov 14, 2022
4D Molecular Therapeutics Inc Interim Clinical Data Presented at NACFC - Corporate Call Transcript
Nov 03, 2022
4D Molecular Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
4D Molecular Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
4D Molecular Therapeutics Inc 4D-310 Phase 1/2 and 4D-110 Phase 1/2 Clinical Data Update Call Transcript
Oct 25, 2021